Dashboard
Manage Tickers

IGMS IGM Biosciences, Inc.


$ 1.28 $ -0.03 (-2.31 %)    

Wednesday, 13-Aug-2025 16:45:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 1.27
$ 1.30
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 0.92 - $ 22.50
1,618,937
na
76.57M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

igm-biosciences-to-be-acquired-by-concentra-biosciences-for-1247-in-cash-per-share-plus-contingent-value-right
IGM Biosciences To Be Acquired By Concentr...
07/01/2025 12:59:55

truist-securities-maintains-hold-on-igm-biosciences-lowers-price-target-to-1
Truist Securities Maintains Hold on IGM Bi...
06/11/2025 17:33:39

Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price targ...

igm-biosciences-q1-eps-050-misses-048-estimate-sales-49900k-miss-310m-estimate
IGM Biosciences Q1 EPS $(0.50) Misses $(0....
05/14/2025 05:30:19

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0...

jp-morgan-upgrades-igm-biosciences-to-neutral
JP Morgan Upgrades IGM Biosciences to Neutral
01/13/2025 18:52:09

JP Morgan analyst Eric Joseph upgrades IGM Biosciences (NASDAQ:IGMS) from Underweight to Neutral.

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/10/2025 21:06:38

crude-oil-surges-3-delta-air-lines-posts-better-than-expected-earnings
Crude Oil Surges 3%; Delta Air Lines Posts...
01/10/2025 19:15:25

nasdaq-down-over-2-walgreens-posts-upbeat-results
Nasdaq Down Over 2%; Walgreens Posts Upbea...
01/10/2025 17:51:22

jefferies-downgrades-igm-biosciences-to-hold-lowers-price-target-to-2
Jefferies Downgrades IGM Biosciences to Ho...
01/10/2025 17:50:02

Jefferies analyst Roger Song downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Hold and lowers the price target from $48 ...

truist-securities-maintains-hold-on-igm-biosciences-lowers-price-target-to-2
Truist Securities Maintains Hold on IGM Bi...
01/10/2025 17:13:00

Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price targ...

stifel-downgrades-igm-biosciences-to-hold-lowers-price-target-to-25
Stifel Downgrades IGM Biosciences to Hold,...
01/10/2025 16:55:20

Stifel analyst Stephen Willey downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Hold and lowers the price target from $27...

rbc-capital-downgrades-igm-biosciences-to-sector-perform-lowers-price-target-to-15
RBC Capital Downgrades IGM Biosciences to ...
01/10/2025 16:39:45

RBC Capital analyst Brian Abrahams downgrades IGM Biosciences (NASDAQ:IGMS) from Outperform to Sector Perform and lowers the...

dow-dips-500-points-us-economy-adds-256000-jobs-in-december
Dow Dips 500 Points; US Economy Adds 256,0...
01/10/2025 15:48:19

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/10/2025 12:05:41

us-stocks-to-open-on-a-tentative-note-as-traders-remain-cautious-ahead-of-fridays-crucial-jobs-data
US Stocks To Open On A Tentative Note As T...
01/10/2025 11:45:29

U.S. stock futures were on a mixed note on Friday ahead of the crucial U.S. jobs data report after a mixed close in the previou...

why-zoomcar-shares-are-trading-higher-by-over-40-here-are-20-stocks-moving-premarket
Why Zoomcar Shares Are Trading Higher By O...
01/10/2025 10:43:12

bmo-capital-downgrades-igm-biosciences-to-market-perform-lowers-price-target-to-2
BMO Capital Downgrades IGM Biosciences to ...
01/10/2025 09:58:17

BMO Capital analyst Etzer Darout downgrades IGM Biosciences (NASDAQ:IGMS) from Outperform to Market Perform and lowers the p...

igm-biosciences-halts-further-development-of-imvotamab-and-igm-2644-plans-reducing-its-workforce-by-73
IGM Biosciences Halts Further Development ...
01/09/2025 18:10:19

"Interim data from the Phase 1b studies of imvotamab in rheumatoid arthritis and systemic lupus erythematosus show that the...

bmo-capital-initiates-coverage-on-igm-biosciences-with-outperform-rating-announces-price-target-of-21
BMO Capital Initiates Coverage On IGM Bios...
12/06/2024 10:52:37

BMO Capital analyst Etzer Darout initiates coverage on IGM Biosciences (NASDAQ:IGMS) with a Outperform rating and announces ...

stifel-maintains-buy-on-igm-biosciences-raises-price-target-to-27
Stifel Maintains Buy on IGM Biosciences, R...
11/11/2024 16:20:14

Stifel analyst Stephen Willey maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $25 to $27.

igm-biosciences-q3-2024-gaap-eps-101-misses-080-estimate-sales-516000k-beat-267222k-estimate
IGM Biosciences Q3 2024 GAAP EPS $(1.01) M...
11/08/2024 12:28:00

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(1.01) per share which missed the analyst consensus estimate of $(0...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION